Phreesia - PHR Stock Forecast, Price & News

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Phreesia in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" PHR shares.
View PHR analyst ratings or view top-rated stocks.

11 brokerages have issued 1 year price targets for Phreesia's stock. Their PHR share price forecasts range from $20.00 to $70.00. On average, they expect the company's share price to reach $36.54 in the next twelve months. This suggests a possible upside of 52.8% from the stock's current price.
View analysts price targets for PHR or view top-rated stocks among Wall Street analysts.

Phreesia's stock was trading at $41.66 at the beginning of the year. Since then, PHR stock has decreased by 42.6% and is now trading at $23.92.
View the best growth stocks for 2022 here.

Phreesia, Inc. (NYSE:PHR) announced its quarterly earnings results on Wednesday, December, 8th. The company reported ($0.46) EPS for the quarter, beating analysts' consensus estimates of ($0.47) by $0.01. The company earned $55.90 million during the quarter, compared to analyst estimates of $48.75 million. Phreesia had a negative net margin of 69.40% and a negative trailing twelve-month return on equity of 36.36%. The company's revenue was up 45.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.17) EPS.

Phreesia issued an update on its FY 2023 earnings guidance on Thursday, September, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $273.00 million-$275.00 million, compared to the consensus revenue estimate of $273.94 million.

172 employees have rated Phreesia Chief Executive Officer Chaim Indig on Glassdoor.com. Chaim Indig has an approval rating of 73% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Phreesia investors own include Fastly (FSLY), Zscaler (ZS), Okta (OKTA), DocuSign (DOCU), HealthEquity (HQY), Block (SQ), Appian (APPN), Walt Disney (DIS), Globant (GLOB) and Invitae (NVTA).

(PHR) raised $127 million in an IPO on Thursday, July 18th 2019. The company issued 7,800,000 shares at $15.00-$17.62 per share. J.P. Morgan, Wells Fargo Securities, William Blair, Allen & Company and Piper Jaffray served as the underwriters for the IPO.

Phreesia trades on the New York Stock Exchange (NYSE) under the ticker symbol "PHR."

Phreesia's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (13.45%), FMR LLC (11.90%), Brown Advisory Inc. (4.15%), Credit Suisse AG (3.78%), Franklin Resources Inc. (2.69%) and Riverbridge Partners LLC (1.94%). Insiders that own company stock include Allison C Hoffman, Allison C Hoffman, Amy Beth Vanduyn, Chaim Indig, Charles Kallenbach, Cheryl Pegus, Daniel Nathan, David Linetsky, Edward L Cahill, Edward L Cahill, Evan Roberts, Gillian Munson, Mark Douglas Smith, Michael J Davidoff, Michael Weintraub, Polaris Venture Management Co, Randy Rasmussen, Scott Perricelli and Thomas Altier.
View institutional ownership trends.

Shares of PHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PHR stock can currently be purchased for approximately $23.92.

Phreesia (NYSE:PHR) has a market capitalization of $1.25 billion and generates $213.23 million in revenue each year. The company earns $-118,160,000.00 in net income (profit) each year or ($3.08) on an earnings per share basis.

The company employs 1,701 workers across the globe.

Phreesia's mailing address is 432 Park Avenue South 12th Floor, New York NY, 10016. The official website for the company is www.phreesia.com. The company can be reached via phone at (888) 654-7473, via email at investors@phreesia.com, or via fax at 646-607-1776.